Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study

Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study

Abstract Background To evaluate 5-year outcomes of anti-vascular endothelial growth factor (VEGF) monotherapy and combination therapy of anti-VEGF agents and photodynamic therapy (PDT) for polypoidal choroidal vasculopathy (PCV) in a real-world Chinese population. Methods Retrospective study. Fifty-...

Full description

Bibliographic Details
Main Authors: Jingyuan Yang, Mingzhen Yuan, Erqian Wang, Song Xia, Youxin Chen
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Ophthalmology
Subjects:
Anti-vascular endothelial growth factor therapy
Combination therapy
Photodynamic therapy
Polypoidal choroidal vasculopathy
Retinal pigment epithelium
Visual acuity
Online Access:http://link.springer.com/article/10.1186/s12886-019-1245-4

Internet

http://link.springer.com/article/10.1186/s12886-019-1245-4

Similar Items